DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN CHILDREN WITH NEWLY DIAGNOSED TYPE-I DIABETES

被引:88
|
作者
COOK, JJ
HUDSON, I
HARRISON, LC
DEAN, B
COLMAN, PG
WERTHER, GA
WARNE, GL
COURT, JM
机构
[1] ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,DEPT DIABET & ENDOCRINOL,PARKVILLE,VIC 3050,AUSTRALIA
[2] ROYAL CHILDRENS HOSP,DEPT ENDOCRINOL & DIABET,PARKVILLE,VIC 3052,AUSTRALIA
[3] ROYAL CHILDRENS HOSP,DEPT BIOSTAT,PARKVILLE,VIC 3052,AUSTRALIA
关键词
D O I
10.2337/diabetes.38.6.779
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:779 / 783
页数:5
相关论文
共 50 条
  • [41] THE BRITISH AND DUTCH MULTICENTER DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS PATIENTS
    MERTIN, J
    MULTIPLE SCLEROSIS RESEARCH, 1989, 843 : 243 - 250
  • [42] A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis
    Palace, J
    Newsom-Davis, J
    Lecky, B
    NEUROLOGY, 1998, 50 (06) : 1778 - 1783
  • [43] AZATHIOPRINE AS A MAINTENANCE TREATMENT FOR CROHN DISEASE - DOUBLE-BLIND WITHDRAWAL TRIAL
    ODONOGHUE, DP
    DAWSON, AM
    POWELLTUCK, J
    BOWN, RL
    BUCKELL, NA
    BURNHAM, WR
    GOULD, SR
    WILLIAMS, CB
    LENNARDJONES, JE
    GASTROENTEROLOGY, 1978, 74 (05) : 1138 - 1138
  • [44] A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
    Assaad-Khalil, Samir
    Elkafrawy, Nabil
    Khaled, Mohsen
    Mogeib, Omneya
    Badr, Hytham
    Rashwan, Ahmed
    Youssef, Mahmoud
    Eltamawy, Khaled
    Mohamed, Shahnaz
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [45] Efficacy and tolerability of lacosamide monotherapy in patients with newly diagnosed epilepsy: A randomized double-blind trial versus controlled-release carbamazepine
    Baulac, M.
    Rosenow, F.
    Toledo, M.
    Terada, K.
    Li, T.
    de Backer, M.
    Werhahn, K. J.
    Brock, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 52 - 52
  • [46] IMPAIRED GROWTH IN CHILDREN WITH POORLY CONTROLLED TYPE-I DIABETES (IDD)
    WHITE, NH
    ROBINSON, GH
    PEDIATRIC RESEARCH, 1987, 21 (04) : A349 - A349
  • [47] Randomized, double-blind, placebo-controlled immunoprevention trial with MUC1 vaccine in patients with newly diagnosed advanced adenomas
    Schoen, Robert E.
    Boardman, Lisa A.
    Cruz-Correa, Marcia
    Bansal, Ajay
    Beatty, Pamela L.
    Kastenberg, David
    Hur, Chin
    Dzubinski, Lynda
    Rodriguez, Luz
    Salazar, Andres
    McKolanis, John
    Seisler, Drew
    Foster, Nathan R.
    Polley, May-Yin
    Limburg, Paul J.
    Finn, Olivera J.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly
    Saetre, Erik
    Perucca, Emilio
    Isojarvi, Jouko
    Gjerstad, Leif
    EPILEPSIA, 2007, 48 (07) : 1292 - 1302
  • [49] Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
    Drayson, Mark T.
    Bowcock, Stella
    Planche, Tim
    Iqbal, Gulnaz
    Pratt, Guy
    Yong, Kwee
    Wood, Jill
    Raynes, Kerry
    Higgins, Helen
    Dawkins, Bryony
    Meads, David
    Hulme, Claire T.
    Monahan, Irene
    Karunanithi, Kamaraj
    Dignum, Helen
    Belsham, Edward
    Neilson, Jeff
    Harrison, Beth
    Lokare, Anand
    Campbell, Gavin
    Hamblin, Michael
    Hawkey, Peter
    Whittaker, Anna C.
    Low, Eric
    Dunn, Janet A.
    LANCET ONCOLOGY, 2019, 20 (12): : 1760 - 1772
  • [50] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOPREVENTION TRIAL WITH MUC1 VACCINE IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED ADENOMAS
    Schoen, Robert E.
    Boardman, Lisa A.
    Cruz-Correa, Marcia R.
    Bansal, Ajay
    Kastenberg, David M.
    Hur, Chin
    Dzubinski, Lynda
    Rodriguez, L. M.
    Salazar, Andres
    McKolanis, John
    Beatty, Pamela
    Pai, Reet
    Seisler, Drew
    Foster, Nathan R.
    Polley, Mei-Yin
    Limburg, Paul
    Finn, Olivera J.
    GASTROENTEROLOGY, 2018, 154 (06) : S873 - S873